347 related articles for article (PubMed ID: 38792060)
21. Therapeutic effect and mechanism of danshensu on coronary heart disease using liquid chromatography combined with mass spectrometry metabolomics.
Zhou P; An B; Zhang X; Lv J; Lin B
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Oct; 1208():123400. PubMed ID: 35917776
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
23. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics: a revolution for novel cancer marker identification.
Bu Q; Huang Y; Yan G; Cen X; Zhao YL
Comb Chem High Throughput Screen; 2012 Mar; 15(3):266-75. PubMed ID: 22221059
[TBL] [Abstract][Full Text] [Related]
25. Mass Spectrometry-based Metabolomics in Translational Research.
Kim SJ; Song HE; Lee HY; Yoo HJ
Adv Exp Med Biol; 2021; 1310():509-531. PubMed ID: 33834448
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics and health: from nutritional crops and plant-based pharmaceuticals to profiling of human biofluids.
Marchev AS; Vasileva LV; Amirova KM; Savova MS; Balcheva-Sivenova ZP; Georgiev MI
Cell Mol Life Sci; 2021 Oct; 78(19-20):6487-6503. PubMed ID: 34410445
[TBL] [Abstract][Full Text] [Related]
27. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
28. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
Yoshida M; Nishiumi S; Azuma T
Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
[TBL] [Abstract][Full Text] [Related]
29. Experimental and Study Design Considerations for Uncovering Oncometabolites.
Haznadar M; Mathé EA
Methods Mol Biol; 2017; 1513():37-47. PubMed ID: 27807829
[TBL] [Abstract][Full Text] [Related]
30. Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging.
Lee DY; Bowen BP; Northen TR
Biotechniques; 2010 Aug; 49(2):557-65. PubMed ID: 20701590
[TBL] [Abstract][Full Text] [Related]
31. Metabolome analysis for discovering biomarkers of gastroenterological cancer.
Suzuki M; Nishiumi S; Matsubara A; Azuma T; Yoshida M
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():59-69. PubMed ID: 24636738
[TBL] [Abstract][Full Text] [Related]
32. Capillary electrophoresis mass spectrometry as a tool for untargeted metabolomics.
García A; Godzien J; López-Gonzálvez Á; Barbas C
Bioanalysis; 2017 Jan; 9(1):99-130. PubMed ID: 27921456
[TBL] [Abstract][Full Text] [Related]
33. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
[TBL] [Abstract][Full Text] [Related]
34. Metabolomics and lipidomics strategies in modern drug discovery and development.
Astarita G; Kelly RS; Lasky-Su J
Drug Discov Today; 2023 Oct; 28(10):103751. PubMed ID: 37640150
[TBL] [Abstract][Full Text] [Related]
35. Systemic and Local Metabolic Alterations in Sleep-Deprivation-Induced Stress: A Multiplatform Mass-Spectrometry-Based Lipidomics and Metabolomics Approach.
Yoon SJ; Long NP; Jung KH; Kim HM; Hong YJ; Fang Z; Kim SJ; Kim TJ; Anh NH; Hong SS; Kwon SW
J Proteome Res; 2019 Sep; 18(9):3295-3304. PubMed ID: 31313932
[TBL] [Abstract][Full Text] [Related]
36. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses.
Serkova NJ; Standiford TJ; Stringer KA
Am J Respir Crit Care Med; 2011 Sep; 184(6):647-55. PubMed ID: 21680948
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in understanding brain cancer metabolomics: a review.
Mukherjee AG; Gopalakrishnan AV; Jayaraj R; Ganesan R; Renu K; Vellingiri B; Dey A; Parveen M
Med Oncol; 2023 Jul; 40(8):220. PubMed ID: 37402029
[TBL] [Abstract][Full Text] [Related]
38. Frontiers of high-throughput metabolomics.
Zampieri M; Sekar K; Zamboni N; Sauer U
Curr Opin Chem Biol; 2017 Feb; 36():15-23. PubMed ID: 28064089
[TBL] [Abstract][Full Text] [Related]
39. Metabolome searcher: a high throughput tool for metabolite identification and metabolic pathway mapping directly from mass spectrometry and using genome restriction.
Dhanasekaran AR; Pearson JL; Ganesan B; Weimer BC
BMC Bioinformatics; 2015 Feb; 16(1):62. PubMed ID: 25887958
[TBL] [Abstract][Full Text] [Related]
40. Clinical applications of metabolomics in oncology: a review.
Spratlin JL; Serkova NJ; Eckhardt SG
Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
